In a significant development for antitrust practitioners and dealmakers, the U.S. Court of Appeals for the Fifth Circuit denied the Federal Trade Commission’s motion for a stay pending appeal in the log standing litigation over the agency’s revised Hart-Scott-Rodino (HSR) filing requirements. The immediate consequence is a reversion to the pre-February 10, 2025 HSR filing framework, introducing practical relief, and near-term uncertainty for transacting parties.

In a brief order, the Fifth Circuit declined to pause the district court’s judgment vacating the new HSR form and instructions, thereby leaving that ruling in effect during the appeal. Consistent with that ruling, the FTC has announced that it is immediately accepting filings under the pre-2025 form and instructions. The agency has also indicated that it will continue to accept filings submitted under the 2025 form on a voluntary basis.

This development temporarily relieves parties of the expanded disclosure requirements introduced in 2025, while creating limited strategic flexibility for those considering whether to proceed under the newer framework. Parties preparing filings should reassess their approach in light of this shift.

The Fifth Circuit has not yet addressed the merits of the appeal, and the ultimate status of the revised HSR requirements remains uncertain. Accordingly, while the prior filing regime is now operative, parties should continue to monitor developments closely as the litigation proceeds.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of John R. Ingrassia John R. Ingrassia

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating…

John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.

For more than 25 years, John has counselled businesses facing the most challenging antitrust issues and helped them stay out of the crosshairs — whether its distribution, pricing, channel management, mergers, acquisitions, joint ventures, or price gouging compliance.

John’s practice focuses on the analysis and resolution of CFIUS and antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger CFIUS and HSR notification requirements. He advises clients on issues related to CFIUS national security reviews, and on CFIUS submissions when non-U.S. buyers seek to acquire U.S. businesses that have national security sensitivities.  He also regularly advises clients on international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes.

His knowledge, reputation and extensive experience with the legal, practical, and technical requirements of merger clearance make him a recognized authority on Hart-Scott-Rodino antitrust merger review. John is regularly invited to participate in Federal Trade Commission and bar association meetings and takes on the issues of the day.

Photo of Timothy E. Burroughs Timothy E. Burroughs

Tim Burroughs is an associate in the Litigation Department and a member of the Antitrust and Commercial Litigation groups. Tim’s practice focuses on assisting clients navigate a range of antitrust issues from investigations and litigation to compliance with pre-merger CFIUS and HSR notification…

Tim Burroughs is an associate in the Litigation Department and a member of the Antitrust and Commercial Litigation groups. Tim’s practice focuses on assisting clients navigate a range of antitrust issues from investigations and litigation to compliance with pre-merger CFIUS and HSR notification requirements. Additionally, Tim has experience representing leading technology, pharmaceutical, and financial services companies in complex commercial disputes throughout the United States.

Tim is a member of the firm’s Antitrust Technology Task Force and a frequent contributor to Proskauer’s Minding Your Business and Proskauer on Price Gouging blogs.

Tim also maintains an active pro bono practice, including representing asylum seekers pursuing claims against the United States for harm suffered in connection with the Trump Administration’s Family Separation Policy.

Tim earned his J.D. from Vanderbilt Law School, where he was the Executive Student Writing Editor for the Vanderbilt Journal of Transnational Law and interned at the U.S. Attorney’s Office for the Southern District of New York.

Prior to his legal career, Tim was a Teach For America corps member and taught elementary school in the Brownsville neighborhood of Brooklyn.